The EGFR 19Del mutation group had more common lung metastasis (88 cases, 24%, P < 0.001), bone metastasis (94 cases, 25.6%, P = 0.048) and pleural metastasis (85 cases, 23.2%, P = 0.027). Here, EGFR is linked to bone metastasis.